Researchers have identified key molecular pathways which lead to late-onset Alzheimer’s disease. The study presents a new approach to Alzheimer’s research and highlights several potential drug targets.
A new study uncovers unique changes in DNA structure in genes important to neuronal function in relatives with early onset, familial Alzheimer’s disease.
Researchers discover presenilin, a protein associated with Alzheimer’s disease, controls the speed at which materials move through brain cells. Defects in presenilin could lead to neuronal blockages with amyloid plaques, commonly associated with this neurodegenerative disorder.
An international research team revealed the atomic‐level structure of the human peptidase enzyme meprin β (beta).
Gene involved in dementia affects the insulin pathway, reports biology professor Chris Li and colleagues. In recent years it became clear that people with diabetes face an ominous prospect – a far greater risk of developing Alzheimer’s disease. Now researchers at The City College of New York (CCNY) have shed light on one reason why. […]
A study led by Karolinska Institutet reports for the first time the positive effects of an active vaccine against Alzheimer’s disease. The new vaccine, CAD106, can prove a breakthrough in the search for a cure for this seriously debilitating dementia disease. The study is published in the distinguished scientific journal Lancet Neurology. Alzheimer’s disease is […]